BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fryczkowski M, Bułdak RJ, Hejmo T, Kukla M, Żwirska-Korczala K. Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer. Dis Markers 2018;2018:3852401. [PMID: 30186533 DOI: 10.1155/2018/3852401] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kamel HFM, Nassir AM, Al Refai AA. Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness. Cancer Med 2020;9:5687-96. [PMID: 32573960 DOI: 10.1002/cam4.3082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Arjmand MH, Moradi A, Akbari A, Mehrad-Majd H. Clinical significance of circulating omentin levels in various malignant tumors: Evidence from a systematic review and meta-analysis. Cytokine 2020;125:154869. [PMID: 31585311 DOI: 10.1016/j.cyto.2019.154869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Panagiotou G, Triantafyllidou S, Tarlatzis BC, Papakonstantinou E. Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology. Int J Endocrinol 2021;2021:6656671. [PMID: 33688343 DOI: 10.1155/2021/6656671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Herrera-Vargas AK, García-Rodríguez E, Olea-Flores M, Mendoza-Catalán MA, Flores-Alfaro E, Navarro-Tito N. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev 2021:S1359-6101(21)00078-2. [PMID: 34736827 DOI: 10.1016/j.cytogfr.2021.10.006] [Reference Citation Analysis]
5 McNally CJ, Ruddock MW, Moore T, McKenna DJ. Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review. Cancer Manag Res 2020;12:5225-41. [PMID: 32669872 DOI: 10.2147/CMAR.S250829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
6 Burton AJ, Gilbert R, Tilling K, Langdon R, Donovan JL, Holly JMP, Martin RM. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis. Sci Rep 2021;11:320. [PMID: 33431998 DOI: 10.1038/s41598-020-79345-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Aslan R, Alp HH, Eryılmaz R, Huyut Z, Sevim M, Araz Ş, Ertas K, Taken K. Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study. Asian Pac J Cancer Prev 2020;21:505-9. [PMID: 32102531 DOI: 10.31557/APJCP.2020.21.2.505] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
8 Krumbholz M, Agaimy A, Stoehr R, Burger M, Wach S, Taubert H, Wullich B, Hartmann A, Metzler M. Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer. Dis Markers 2019;2019:5085373. [PMID: 31915468 DOI: 10.1155/2019/5085373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Zhou L, He W, Wang W, Zhou D. Altered circulating levels of adipokine omentin-1 in patients with prostate cancer. Onco Targets Ther 2019;12:3313-9. [PMID: 31118682 DOI: 10.2147/OTT.S197507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
10 Wang YX, Zhu N, Zhang CJ, Wang YK, Wu HT, Li Q, Du K, Liao DF, Qin L. Friend or foe: Multiple roles of adipose tissue in cancer formation and progression. J Cell Physiol 2019;234:21436-49. [PMID: 31054175 DOI: 10.1002/jcp.28776] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
11 Miyata Y, Shida Y, Hakariya T, Sakai H. Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer. Molecules 2019;24:E193. [PMID: 30621039 DOI: 10.3390/molecules24010193] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
12 Sun X, Ye D, Du L, Qian Y, Jiang X, Mao Y. Genetically predicted levels of circulating cytokines and prostate cancer risk: A Mendelian randomization study. Int J Cancer 2020;147:2469-78. [PMID: 33460126 DOI: 10.1002/ijc.33221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cintho Ozahata M, Page GP, Guo Y, Ferreira JE, Dinardo CL, Carneiro-Proietti ABF, Loureiro P, Mota RA, Rodrigues DOW, Belisario AR, Maximo C, Flor-Park MV, Custer B, Kelly S, Sabino EC; International Component of the NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III). Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study. J Sex Med 2019;16:1988-99. [PMID: 31668730 DOI: 10.1016/j.jsxm.2019.09.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhai T, Wu X, Zhang N, Huang X, Zhan Q. Inflammatory risk factors for hypertriglyceridemia in patients with severe influenza. J Int Med Res 2020;48:300060520918058. [PMID: 32776792 DOI: 10.1177/0300060520918058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jalali A, Kitching M, Martin K, Richardson C, Murphy TB, FitzGerald SP, Watson RW, Perry AS. Integrating inflammatory serum biomarkers into a risk calculator for prostate cancer detection. Sci Rep 2021;11:2525. [PMID: 33510263 DOI: 10.1038/s41598-021-81965-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]